Published by Alexander Bueso on 19th September 2021
(Sharecast News) - The trial of a new drug to treat an aggressive form of breast cancer has "shattered expectations" raising hopes of a "cure", according to its maker, AstraZeneca. The British pharmaceuticals company said three quarters of women in the trial of its new drug, Enhertu, had shown no progression in their disease after 12 months compared with just a third treated with a different medicine. - Sunday Times